Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company developing ITK inhibitors for cancer and immune diseases. Its lead product candidate, soquelitinib, is an oral small molecule drug designed to selectively inhibit ITK.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.